These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1855351)

  • 1. Doxapram metabolism in human fetal hepatic organ culture.
    Bairam A; Branchaud C; Beharry K; Rex J; Laudignon N; Papageorgiou A; Aranda JV
    Clin Pharmacol Ther; 1991 Jul; 50(1):32-8. PubMed ID: 1855351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe side effects and drug plasma concentrations in preterm infants treated with doxapram.
    Barbé F; Hansen C; Badonnel Y; Legagneur H; Vert P; Boutroy MJ
    Ther Drug Monit; 1999 Oct; 21(5):547-52. PubMed ID: 10519454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal absorption of doxapram in neonates.
    Bairam A; Akramoff-Gershan L; Beharry K; Laudignon N; Papageorgiou A; Aranda JV
    Am J Perinatol; 1991 Mar; 8(2):110-3. PubMed ID: 2006935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an LC-MS/MS method for simultaneously determining doxapram and keto-doxapram in human serum.
    Suzuki Y; Kamada N; Ohno H; Abe Y; Endo T; Kobayashi M
    Bioanalysis; 2017 Mar; 9(6):503-515. PubMed ID: 28225296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic study of doxapram in patients and volunteers.
    Robson RH; Prescott LF
    Br J Clin Pharmacol; 1979 Jan; 7(1):81-7. PubMed ID: 32901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants.
    Flint RB; Weteringen WV; Voller S; Poppe JA; Koch BCP; de Groot R; Tibboel D; Knibbe CAJ; Reiss IKM; Simons SHP; Dino Research Group
    Curr Pharm Des; 2017; 23(38):5919-5927. PubMed ID: 28925893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolites of doxapram in premature neonates.
    Coutts RT; Jamali F; Malek F; Peliowski A; Finer NN
    Xenobiotica; 1991 Oct; 21(10):1407-18. PubMed ID: 1796617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue.
    Kraft M; Foerster KI; Wiedmann F; Sauter M; Paasche A; Blochberger PL; Yesilgöz B; L'hoste Y; Frey N; Haefeli WE; Burhenne J; Schmidt C
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects and pharmacokinetic profiles of keto-doxapram and doxapram in newborn lambs.
    Bairam A; Blanchard PW; Mullahoo K; Beharry K; Laudignon N; Aranda JV
    Pediatr Res; 1990 Aug; 28(2):142-6. PubMed ID: 2395604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition of intravenous doxapram in man.
    Clements JA; Robson RH; Prescott LF
    Eur J Clin Pharmacol; 1979; 16(6):411-6. PubMed ID: 527638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E; Benard M; Hamon I; Casper C; Haddad FE; Boutroy MJ; Hascoët JM
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of taurocholate by rat fetal liver in organ culture: effects of cortisol in vitro.
    Graham TO; Van Thiel DH; Little JM; Lester R
    Am J Physiol; 1979 Aug; 237(2):E177-84. PubMed ID: 223454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of doxapram and 2-ketodoxapram in plasma of neonates by gas chromatography.
    LeGatt DF; Beaudry MA; Bradley JM
    J Chromatogr; 1986 Jun; 378(2):478-81. PubMed ID: 3734004
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of prolactin (PRL) on human fetal lung and liver protein synthesis in vitro.
    Genbacev O; Vićovac L; Sulović V
    J Perinat Med; 1983; 11(5):258-60. PubMed ID: 6196473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-related differences in doxapram-induced alteration of drug action in the rat.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):397-400. PubMed ID: 2813960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol-induced accumulation of phospholipids in organ culture of human fetal lung.
    Ekelund L; Arvidson G; Astedt B
    Scand J Clin Lab Invest; 1975 Sep; 35(5):419-23. PubMed ID: 1188296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of doxapram metabolites using high pressure ion exchange chromatography and mass spectroscopy.
    Pitts JE; Bruce RB; Forehand JB
    Xenobiotica; 1973 Feb; 3(2):73-83. PubMed ID: 4716642
    [No Abstract]   [Full Text] [Related]  

  • 20. Bile acid conjugation in organ culture of human fetal liver.
    Haber LR; Vaupshas V; Vitullo BB; Seemayer TA; de Belle RC
    Gastroenterology; 1978 Jun; 74(6):1214-23. PubMed ID: 648811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.